Evidence map›Paper›PMID 42228320›Full record

ArticleDrug delivery and translational research2026

Solid microneedle booster as an enhanced microneedling platform for the treatment of androgenetic alopecia.

Jiwoo Shin, Jinhyeok Song, Paul Kim, Huisuk Yang, Hyungil Jung

Abstract read
PubMed Publisher
In one paragraph

Article in Drug delivery and translational research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jiwoo Shin *Department of Biotechnology, Yonsei University, Building 123, 50 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Korea.
Jinhyeok Song *Department of Integrative Biotechnology, Building 123, Yonsei University, 85, Songdogwahak-ro, Incheon, 21983, Korea.
Paul KimJuvic Inc, 272 Digital-ro, Guro-gu, Seoul, 08389, Korea.
Huisuk YangJuvic Inc, 272 Digital-ro, Guro-gu, Seoul, 08389, Korea.
Hyungil JungDepartment of Biotechnology, Yonsei University, Building 123, 50 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Korea. hijung@yonsei.ac.kr.

Funding

Korea Institute for Advancement of Technology RS-2024-00418203Seoul RISE Center 2025-RISE-01-022-05
6 · The paper itself

Abstract

Solid microneedle (SMN) is used to enhance transfollicular delivery in androgenetic alopecia (AGA); however, user-dependent kinematics can generate irregular microchannels that require sequential drug application. Here, we developed a one-step solid microneedle booster (SMB) that combines spring-driven perpendicular stamping with simultaneous liquid dosing. This circumvents the spatial and temporal mismatch inherent in traditional two-step methods, improving microchannel reproducibility and early transport. In porcine skin, rhodamine B mapping exhibited higher microchannel surface coverage for SMB than that of the roller at 20 matched applications, with SMB producing deeper penetration. Functional delivery was evaluated by Franz diffusion using ascorbic acid as a hydrophilic probe of microchannel-assisted permeation. Across the various tested conditions, SMB consistently produced a stronger early-phase permeation enhancement than that of the roller, and this early advantage was reflected in the cumulative delivery at later time points. SMB-assisted minoxidil (MXD) delivery accelerated hair regrowth in vivo compared with roller-assisted delivery under matched treatment settings, and histological analysis supported these outcomes as it revealed a greater enrichment of deep follicles in the SMB + MXD groups. Collectively, SMB provides a directionality-controlled, one-step microneedling platform that enhances the early, front-loaded transport and promotes follicular maturation, with AGA serving as a representative model for the broader applications of dermatologic delivery.

Indexed as

Androgenetic alopeciaMicroneedlingSkin barrier enhancementTransdermal delivery

Identifiers

PMID42228320

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.